findmyKOL
Clinical trialNCT06809400RecruitingPhase 1Interventional

A Study of LY4006896 in Healthy Participants and Participants With Parkinson's Disease

SponsorEli Lilly and CompanyEnrollment127Parkinson Disease
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

The purpose of this study is to generate evidence of the safety, tolerability, and pharmacokinetics/pharmacodynamics of IV LY4006896 compared with placebo in healthy participants and participants with Parkinson's disease.

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Eli Lilly and Company

    Study Director

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

14 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Japan
  • P-One Clinic

    Hachiōji, Japan

    Kenichi Furihata
    Recruiting
  • Oita University Hospital

    Yufu, Japan

    Naoto Uemura
    Recruiting
United States
  • Collaborative Neuroscience Network - Cns

    Los Alamitos, California, United States

    Steven Reynolds
    Recruiting
  • Collaborative Neuroscience Network - Cns

    Los Alamitos, California, United States

    Omid Omidvar
    Recruiting
  • K2 Medical Research, Llc

    Maitland, Florida, United States

    Completed
  • Aqualane Clinical Research

    Naples, Florida, United States

    William Justiz
    Recruiting
  • Charter Research

    Orlando, Florida, United States

    Diana Balsalobre
    Recruiting
  • Progressive Medical Research

    Port Orange, Florida, United States

    Alexander White
    Recruiting
  • Charter Research

    The Villages, Florida, United States

    Jeffrey Norton
    Recruiting
  • K2 Medical Research, Llc

    The Villages, Florida, United States

    Craig Curtis
    Recruiting
  • Quest Research Institute

    Farmington Hills, Michigan, United States

    Aaron Ellenbogen
    Recruiting
  • Ppd Development, Lp

    Austin, Texas, United States

    Sabrina Merchant
    Recruiting
  • Evergreen Health Research

    Kirkland, Washington, United States

    Not, yet, recruiting
  • Inland Northwest Research

    Spokane, Washington, United States

    Jason Aldred
    Not, yet, recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

LY4006896Placebo
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
18 Feb 2025
Primary completion
31 Jan 2028
Completion
31 Jan 2028
Last update posted
20 Apr 2026
Registered enrollment
127
Registry id
NCT06809400

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.